2022
DOI: 10.1016/j.clinthera.2021.11.003
|View full text |Cite
|
Sign up to set email alerts
|

Willingness to Accept Expedited COVID-19 Vaccine Research for Children Aged <12 Years After Adult Vaccine Approval

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 21 publications
0
2
0
Order By: Relevance
“…Other surveys among parents of healthy children of similar age have observed considerably higher prevalence. Indeed, the willingness towards the vaccination was 93.6% for children aged 5–8 years in Brazil [ 22 ], 87.9% among 9–11-year-olds in Canada [ 23 ], 86.75% for 3–6 years in China [ 24 ], 65.2% for children with a median age of 7.5 years in a multicenter survey in the United States, Canada, Israel, Spain, and Switzerland [ 25 ], 45.9% for those aged 5–10 years in the United States [ 26 ], and 42.9% for children with an average age of 7.4 years in Japan [ 27 ]. Moreover, prevalence of the participants that were found to be vaccine high-hesitant was higher than the value of 15.7%, reported in a study that used the PACV-15 tool in China [ 28 ], and 12.4% with the PACV-5 in Italy [ 14 ].…”
Section: Discussionmentioning
confidence: 99%
“…Other surveys among parents of healthy children of similar age have observed considerably higher prevalence. Indeed, the willingness towards the vaccination was 93.6% for children aged 5–8 years in Brazil [ 22 ], 87.9% among 9–11-year-olds in Canada [ 23 ], 86.75% for 3–6 years in China [ 24 ], 65.2% for children with a median age of 7.5 years in a multicenter survey in the United States, Canada, Israel, Spain, and Switzerland [ 25 ], 45.9% for those aged 5–10 years in the United States [ 26 ], and 42.9% for children with an average age of 7.4 years in Japan [ 27 ]. Moreover, prevalence of the participants that were found to be vaccine high-hesitant was higher than the value of 15.7%, reported in a study that used the PACV-15 tool in China [ 28 ], and 12.4% with the PACV-5 in Italy [ 14 ].…”
Section: Discussionmentioning
confidence: 99%
“…The available studies in the US show race and ethnicity, gender, age, vaccine status, education, parents’ COVID-19 infection, and COVID-19 death exposure are associated with parents’/guardians’ intentions to vaccinate their child against COVID-19 [ 16 , 17 , 18 ]. Many published studies in the US used nonrandom samples [ 19 , 20 , 21 ], and very few peer-reviewed, representative samples surveyed parents/guardians after the EUA authorization for children 12–17. This leaves a significant gap in the literature.…”
Section: Introductionmentioning
confidence: 99%